"Rh-Hr Blood-Group System" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Erythrocyte isoantigens of the Rh (Rhesus) blood group system, the most complex of all human blood groups. The major antigen Rh or D is the most common cause of erythroblastosis fetalis.
| Descriptor ID |
D012204
|
| MeSH Number(s) |
D23.050.301.290.775 D23.050.705.230.775
|
| Concept/Terms |
Rh-Hr Blood-Group System- Rh-Hr Blood-Group System
- Blood-Group System, Rh-Hr
- Blood-Group Systems, Rh-Hr
- Rh Hr Blood Group System
- Rh-Hr Blood-Group Systems
- System, Rh-Hr Blood-Group
- Systems, Rh-Hr Blood-Group
- Rhesus Blood-Group System
- Blood-Group System, Rhesus
- Blood-Group Systems, Rhesus
- Rhesus Blood Group System
- Rhesus Blood-Group Systems
- System, Rhesus Blood-Group
- Systems, Rhesus Blood-Group
Rh Factors- Rh Factors
- Factor, Rh
- Factors, Rh
- Rh Factor
|
Below are MeSH descriptors whose meaning is more general than "Rh-Hr Blood-Group System".
Below are MeSH descriptors whose meaning is more specific than "Rh-Hr Blood-Group System".
This graph shows the total number of publications written about "Rh-Hr Blood-Group System" by people in this website by year, and whether "Rh-Hr Blood-Group System" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 3 | 0 | 3 |
| 1999 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2010 | 1 | 2 | 3 |
| 2013 | 2 | 0 | 2 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rh-Hr Blood-Group System" by people in Profiles.
-
A novel algorithm comprehensively characterizes human RH genes using whole-genome sequencing data. Blood Adv. 2020 09 22; 4(18):4347-4357.
-
Cancer type predicts alloimmunization following RhD-incompatible RBC transfusions. Transfusion. 2017 04; 57(4):952-958.
-
Circulating Cell-Free DNA to Determine the Fetal RHD Status in All Three Trimesters of Pregnancy. Obstet Gynecol. 2016 12; 128(6):1340-1346.
-
Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity? BMJ. 2015 Nov 26; 351:h5079.
-
Phasing-in RHD genotyping. Arch Pathol Lab Med. 2014 May; 138(5):585-8.
-
Weak D types in the Egyptian population. Am J Clin Pathol. 2013 Jun; 139(6):806-11.
-
RHD zygosity predicts degree of platelet response to anti-D immune globulin treatment in children with immune thrombocytopenia. Pediatr Blood Cancer. 2013 Sep; 60(9):E106-8.
-
Comparison of estimation of volume of fetomaternal hemorrhage using Kleihauer-Betke test and microcolumn gel method in D-negative nonisoimmunized mothers. Immunohematology. 2013; 29(3):105-9.
-
A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expression. Am J Hematol. 2012 Mar; 87(3):266-71.
-
Hemolytic disease of newborn due to anti-Jk b in a woman with high risk pregnancy. Transfus Apher Sci. 2010 Aug; 43(1):41-3.